​Investment update: MyTomorrows raise €10m

It gives us great pleasure to share the news that MyTomorrows have raised €10m. We are delighted to have participated in the round, which was led by Octopus Ventures and EQT Ventures, with Soffinova Ventures also participating. Balderton initially led a €4.5m investment in the company in 2014.

MyTomorrows CEO and CoFounder Ronald Brus

This is great news for MyTomorrows, who are continuing their mission to save lives, by enabling patients with unmet medical needs to access clinical trials and early access programmes. The company is now active in 17 countries and will use this funding to accelerate their own investment in technology and talent.

More coverage of the investment here

Stay in touch with Balderton

Sign up for our newsletter to stay up to date on news from Balderton, and our portfolio.